Practice valuation and exit planning for dentists

May 6, 2026 · Pouyan Golshani, MD, Interventional Radiologist

DSO consolidation is reshaping dentistry exits. Here’s how to value your practice, evaluate a sale, and structure the transaction.

For decades, the path for a successful dentist was straightforward: build a practice, work for 30-40 years, and sell to a younger associate. That model is rapidly being replaced by sales to private equity-backed Dental Service Organizations (DSOs). While these deals can offer life-changing liquidity, the headline price is only a fraction of the story. The real value—and the biggest traps—are buried in the deal structure, tax implications, and equity arrangements. Most of us learn this the hard way, by seeing a colleague’s “great deal” get decimated by taxes or restrictive covenants. This article breaks down the key components of a modern dental practice sale, from valuation drivers to the tax strategies that preserve your wealth. For a deeper dive into the operational and financial side of your practice, explore our full suite of dentistry free tools and resources.

Practice Valuation Drivers and EBITDA Multiples

When a DSO evaluates your practice, they aren’t just looking at your gross revenue. They are buying a stream of future cash flow, and the primary metric they use to measure it is EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization. In simple terms, it’s a proxy for your practice’s operating profitability.

Calculating your practice’s “adjusted” or “normalized” EBITDA is the first step in any valuation. This involves taking your net income and adding back interest, taxes, depreciation, and amortization. Crucially, you also add back non-recurring or discretionary owner expenses that a new owner wouldn’t incur. These “add-backs” can include your personal auto lease, family cell phone plans, above-market owner salary, or retirement plan contributions that are really a form of owner compensation. A higher adjusted EBITDA directly translates to a higher valuation.

The DSO then applies a multiple to this adjusted EBITDA figure to arrive at a purchase price. For example, a practice with $500,000 in adjusted EBITDA might command a 6x multiple, resulting in a $3,000,000 valuation. The size of that multiple is determined by several key factors:

Recurring Revenue: Practices with strong hygiene programs, in-house membership plans, or a high percentage of recurring patient visits are less risky and command higher multiples.
Provider Mix: A practice where revenue is generated by multiple associates is more valuable than one dependent on a single owner-operator. The DSO is buying a system, not just one person’s production.
Location and Demographics: Practices in growing, affluent areas with multiple operatories and room for expansion are prime targets.
Service Mix: A practice offering high-margin specialty services like implants, orthodontics, or sleep apnea appliances will often receive a higher multiple than a general bread-and-butter practice.
Infrastructure: Modern equipment (CBCT, digital scanners), a well-trained team, and efficient operational systems (like a strong recall program) all contribute to a higher valuation.

The most common trap is focusing on top-line revenue while ignoring profitability. A $2 million practice with a 15% EBITDA margin ($300,000) is far less valuable than a $1.5 million practice with a 30% margin ($450,000). Before you even think about selling, your focus should be on maximizing and documenting your adjusted EBITDA.

Private Equity Buyout Tax Structuring: Asset vs. Stock Sale

When I look at a term sheet from a DSO, the first thing I check isn’t the price—it’s the proposed transaction structure. This single detail can swing your net, after-tax proceeds by hundreds of thousands of dollars. The two primary structures are an asset sale and a stock sale, and they have vastly different tax consequences for you, the seller.

In an asset sale, the DSO buys the individual assets of your practice: the chairs, the computers, your patient list (goodwill), and your accounts receivable. Your legal entity (your S-Corp or LLC) remains, now holding only the cash from the sale. DSOs overwhelmingly prefer this structure because it allows them to “step-up” the basis of the assets they purchase, giving them significant future depreciation deductions. For you, however, it’s often a tax nightmare. The proceeds are allocated to different asset classes, each with its own tax treatment. Gain on fully depreciated equipment is “recaptured” and taxed as ordinary income, at rates up to 37%. Your collected accounts receivable are also ordinary income. Only the portion allocated to goodwill typically qualifies for the lower long-term capital gains rate (15-20%).

In a stock sale, the DSO buys the shares of your corporation directly. They acquire the entire entity, including all its assets and liabilities. For you, the seller, this is usually the ideal outcome. The entire difference between your sale price and your stock basis is treated as a long-term capital gain, taxed at the preferential lower rate. It’s clean, simple, and tax-efficient.

The planning trap here is immense. Many dentists see a high offer price and accept an asset sale structure without realizing the tax bite. If a DSO insists on an asset sale for their own tax reasons, you must negotiate a higher purchase price to make you whole on an after-tax basis. This is a non-negotiable point of leverage. You need a deal team—an M&A attorney and a CPA who specialize in dental transactions—to model the after-tax outcomes of both structures and fight for the one that benefits you.

Equity Rollover Deal Mechanics

A common feature of modern DSO deals is the “equity rollover.” Instead of an all-cash buyout, the DSO will offer a combination of cash and equity in the larger, newly formed parent company. For example, on a $5 million valuation, the offer might be $4 million in cash at closing and $1 million of your sale proceeds “rolled over” into stock of the new DSO entity.

The primary benefit of this structure is tax deferral. Under specific IRS rules (like Section 351), the portion of your sale that is exchanged for stock is not a taxable event at the time of the transaction. You only owe capital gains tax on that rolled equity when a future “second liquidity event” occurs—for instance, when the DSO is sold to an even larger private equity fund five to seven years down the road. This allows your pre-tax dollars to remain invested and potentially grow.

This is often pitched as getting a “second bite of the apple.” If the DSO successfully executes its growth plan, your $1 million in rollover equity could be worth $2 million, $3 million, or more at the next sale. It aligns your incentives with the new owner and gives you continued upside in the platform you helped build. However, it is not without significant risk.

The trap is viewing rollover equity as guaranteed money. It is not. It is an illiquid, concentrated, and often minority-stake investment in a highly leveraged private company. If the DSO’s growth stalls or it fails, that equity could be worth zero. Your due diligence can’t stop at your own practice; you are now an investor in the private equity fund and their management team. You must scrutinize their track record, their financial projections for the combined entity, and the terms of the equity you’re receiving (e.g., are you getting the same class of shares as the PE fund?). A lower all-cash offer can sometimes be superior to a higher offer with a large, risky rollover component.

R&D Tax Credits for Proprietary Processes and Technology

One of the most overlooked financial strategies for innovative dental practices is the Research and Development (R&D) tax credit. Most dentists hear “R&D” and think of pharmaceutical companies, not their own clinical work. But the definition under Internal Revenue Code §41 is much broader than you might expect. It applies to activities intended to develop or improve a product, process, technique, or software.

Many activities in a modern dental practice can qualify. Are you:

Developing a new technique or workflow for placing implants?
Experimenting with different materials or fabrication processes for custom sleep apnea appliances or surgical guides?
Creating or significantly modifying internal software to track complex case outcomes or streamline patient communication?
Testing new sterilization processes to improve efficiency or efficacy?

If you are systematically testing hypotheses to eliminate uncertainty and improve a process, the associated costs—including a portion of the wages for the dentists and staff involved, as well as supply costs—can qualify for the credit. This isn’t a deduction; it’s a dollar-for-dollar credit against your income taxes, making it incredibly valuable. For a qualifying practice, this can translate into tens of thousands of dollars in tax savings annually.

The trap is a lack of documentation. You can’t simply claim the credit without proof. You need to contemporaneously document the projects you’re undertaking, the technical uncertainties you’re trying to resolve, and the process of experimentation. Most dentists are already doing the work; they just fail to document it in a way that satisfies IRS requirements. Engaging a specialty firm that understands the R&D credit for medical and dental practices is often necessary to properly scope the qualifying activities and prepare the required documentation for Form 6765. It’s found money that most of your peers are leaving on the table.

Cost Segregation Studies for Practice Real Estate

For dentists who own the building their practice operates in, a cost segregation study is one of the most powerful tax strategies available. When you buy a commercial property, the building is typically depreciated over a 39-year straight-line schedule. A cost segregation study is an engineering-based analysis that dissects the components of your building and reclassifies them into shorter-lived asset classes.

Instead of treating the entire structure as 39-year property, the study identifies components that qualify for 5, 7, or 15-year depreciation schedules. For a dental office, this can include a significant portion of the build-out:

5-Year Property: Carpeting, specialty cabinetry, decorative lighting, and other non-structural fixtures.
7-Year Property: Office furniture and equipment.
15-Year Property: Land improvements like parking lots, sidewalks, and landscaping.

By reclassifying, say, 25% of a $1 million building’s cost from a 39-year life to a 5-year life, you can dramatically accelerate your depreciation deductions. Instead of a small deduction each year for 39 years, you get a massive deduction in the first few years. With current “bonus depreciation” rules (though they are phasing down), you can often deduct 100% of the cost of these shorter-lived assets in the year the property is placed in service. This can create a huge paper loss that can offset other active income.

The trap is thinking this is only for new construction. A cost segregation study can be performed on a property you purchased years ago, allowing for a “catch-up” depreciation deduction in the current year for all the depreciation you missed. For dentists in high tax brackets, this can generate a tax refund of $50,000 to $100,000 or more, depending on the property’s size. You can model different scenarios with a real estate investing calculator to see the potential impact. This strategy, especially when paired with Real Estate Professional Status for a spouse, can be a cornerstone of wealth building outside of your clinical income. The physician finance hub can help identify if strategies like this are a good fit for your specific financial situation by analyzing your income, investments, and real estate holdings.

Navigating a practice sale in the era of DSO consolidation requires a strategic mindset that goes far beyond clinical excellence. Understanding valuation, tax structuring, and equity mechanics is just as critical as your skill with a handpiece. These concepts are not just abstract financial theory; they are the tools that determine how much of your life’s work you actually get to keep. Before you sign any letter of intent, ensure you have a team that can model these outcomes for you. For an independent analysis of a specific offer on your desk, you can request a diligence memo on a DSO offer to get an objective, physician-led perspective.